Literature DB >> 21327537

Stability-indicating spectrofluorimetric method for the assay of ziprasidone in capsules.

Mohamed I Walash1, Fathalla Belal, Nahed El-Enany, Manal Eid, Rania N El-Shaheny.   

Abstract

A simple, rapid and highly sensitive spectrofluorimetric method was developed for determination of ziprasidone hydrochloride (ZPS) in capsules. The method is based on measuring the native fluorescence of ZPS in acetate buffer of pH 4.5 at 398 nm after excitation at 315 nm. The fluorescence-concentration plot was rectilinear over the range of 0.05-0.80 μg mL(-1) with a lower detection limit (LOD) of 6.0 ng mL(-1) and quantification limit (LOQ) of 20.0 ng mL(-1). The method was fully validated and successfully applied to the determination of ZPS in its capsules with average percentage recovery of 99.7 ± 1.4. The method was extended to stability study of ZPS. The drug was exposed to acidic, alkaline, oxidative and photolytic degradation according to ICH guidelines. Moreover, the method was utilized to investigate the kinetics of the alkaline, acidic and oxidative degradation of the drug. A proposal for the degradation pathways was postulated. © Springer Science+Business Media, LLC 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21327537     DOI: 10.1007/s10895-011-0855-x

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  8 in total

1.  Determination of plasma ziprasidone using liquid chromatography with fluorescence detection.

Authors:  Raymond F Suckow; Mira Fein; Christoph U Correll; Thomas B Cooper
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-01-25       Impact factor: 3.205

2.  Simultaneous determination of five antipsychotic drugs in rat plasma by high performance liquid chromatography with ultraviolet detection.

Authors:  Guodong Zhang; Alvin V Terry; Michael G Bartlett
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-05-26       Impact factor: 3.205

3.  Determination of Ziprasidone in pharmaceutical formulations by capillary zone electrophoresis.

Authors:  Cecilia Farina; Leopold Kremser; Maria Augusta Raggi; Ernst Kenndler
Journal:  J Pharm Biomed Anal       Date:  2007-11-17       Impact factor: 3.935

4.  Rapid liquid chromatography-tandem mass spectrometry method for quantification of ziprasidone in human plasma.

Authors:  Osama Y Al-Dirbashi; Hassan Y Aboul-Enein; Ahmed Al-Odaib; Minnie Jacob; Mohamed S Rashed
Journal:  Biomed Chromatogr       Date:  2006-04       Impact factor: 1.902

5.  Liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat plasma.

Authors:  Guodong Zhang; Alvin V Terry; Michael G Bartlett
Journal:  Rapid Commun Mass Spectrom       Date:  2007       Impact factor: 2.419

6.  Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat brain tissue.

Authors:  Guodong Zhang; Alvin V Terry; Michael G Bartlett
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-08-17       Impact factor: 3.205

7.  Stability indicating reversed-phase high-performance liquid chromatographic and thin layer densitometric methods for the determination of ziprasidone in bulk powder and in pharmaceutical formulations.

Authors:  Zeinab A El-Sherif; Badr El-Zeany; Ola M El-Houssini; Mohamed S Rashed; Hassan Y Aboul-Enein
Journal:  Biomed Chromatogr       Date:  2004-04       Impact factor: 1.902

8.  Determination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography-tandem mass spectrometry.

Authors:  Guodong Zhang; Alvin V Terry; Michael G Bartlett
Journal:  Biomed Chromatogr       Date:  2008-07       Impact factor: 1.902

  8 in total
  1 in total

Review 1.  Studies on photodegradation process of psychotropic drugs: a review.

Authors:  Jakub Trawiński; Robert Skibiński
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-30       Impact factor: 4.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.